Cite
HARVARD Citation
Skougaard, K. et al. (n.d.). 715 Early 18F-FDG PET/CT as predictive marker of treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab. European journal of cancer. pp. S132-. [Online].